LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 107 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,254,771 | -51.1% | 516,367 | -61.6% | 0.00% | -55.6% |
Q4 2022 | $2,567,290 | -70.4% | 1,344,131 | -62.8% | 0.01% | -74.3% |
Q3 2022 | $8,672,000 | +445.4% | 3,613,500 | +584.2% | 0.04% | +250.0% |
Q3 2019 | $1,590,000 | -71.0% | 528,100 | +38.1% | 0.01% | -67.7% |
Q1 2017 | $5,485,000 | – | 382,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |